Old CIC Events

Stromal cytokine signalling promotes breast cancer progression by reprograming the tumor microenvironment
María Muñoz Caffarel — del Instituto de Investigación Sanitaria Biodonostia/ Hospital Donostia de San Sebastián

Insights into ALK biology to unravel novel therapeutic pathways
Claudia Voena — Center for Experimental Research and Medical Studies (CeRMS) University of Torino

Molecular mechanisms of DNA crosslink recognition and repair
Pablo Alcón — Medical Research Council Laboratory of Molecular Biology (MRC-LMB), Cambridge (United Kingdom).

Transient JAK/STAT pathway inhibition prevents B-ALL development in genetically predisposed mice
Ana Casado García — Centro de Investigación del Cáncer (CIC-IBMCC), Salamanca

Novel therapeutic strategies against cancer metastasis: From Research to Innovation
Angélica Figueroa — Instituto de Investigación Biomédica A Coruña (INIBIC)

Epigenetic control of tissue plasticity in pancreatic regeneration and tumorigenesis.
Direna Alonso Curbelo — IRB, Barcelona

Understanding early lymphoma formation from a single-cell epigenomics and 3D chromatin perspective
Renée Beekman — Center for Genomic Regulation (CRG)

USAL Program Medical Immunology 2022 (1st Edition)
Prof. Jacques J.M van Dongen — Centro de Investigación del Cáncer-Instituto de Biología Celular y Molecular del Cáncer y Leiden University Medical Center.

A truncating variant of RAD51B associated with primary ovarian insufficiency provides insights into its meiotic and somatic functions
Yazmine Bejarano — Centro de Investigación del Cáncer

PCNA- deubiquitinating enzymes associate with Replication Forks to ensure a precise progression through S-phase
Javier Zamarreño — Centro de Investigación del Cáncer, (CIC, IBMCC), Salamanca

Mechanisms of gene regulation after fertilization: from transcription to decay
Antonio Giráldez — Yale University School of Medicine.

Protein bombs and liquid adhesions in immune cell mediated killing in cancer and infection
Michael Dustin — University of Oxford